Asston Pharmaceuticals IPO Sales, Profits, and other Financial Details - What you should know about the Asston Pharmaceuticals IPO

Asston Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Financial Information of Asston Pharmaceuticals Limited IPO
The Revenues from operations for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 620.93, ₹ 2,561.02 Lakh, ₹ 1,584.09 Lakh and ₹ 719.19 Lakh. The EBITDA for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 194.90, ₹ 673.03 Lakh, ₹ 280.06 Lakh and ₹ 217.05 Lakh. The Profit after Tax for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 132.24, ₹ 432.51 Lakh, ₹ 136.03 Lakh and ₹ 105.66 Lakh respectively. This indicates a steady growth in financial performance.

Asston Pharmaceuticals Limited Financial Information (Restated Consolidated)

Amount in (₹ in Lakh)

Period Ended	May 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Reserve of Surplus	576.87	444.63	560.86	128.59
Total Assets	3,183.43	2,812.26	2,026.02	1,369.42
Total Borrowings	783.28	725.72	681.99	524.51
Fixed Assets	93.44	95.56	109.10	113.14
Cash	21.50	19.91	0.64	12.37
Net Borrowing	761.78	705.81	681.35	512.14
Revenue	620.93	2,561.02	1,584.09	719.19
EBITDA	194.90	673.03	280.06	217.05
PAT	132.24	432.51	136.03	105.66
EPS	2.11	6.9	2.37	1.89

Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.